HCPLive Network

Implementing Care Transition Initiative Decreases Rehospitalizations

 
WEDNESDAY, Jan. 23 (HealthDay News) -- Communities instituting quality improvement initiatives for care transitions see significant declines in the rate of 30-day rehospitalizations and hospitalizations, according to a study published in the Jan. 23/30 issue of the Journal of the American Medical Association.

Jane Brock, M.D., M.S.P.H., from the Colorado Foundation for Medical Care in Englewood, and colleagues from the Care Transitions Project evaluated the effect of an evidence-based quality improvement initiative undertaken by the Medicare Quality Improvement Organization staff. Performance differences were compared for 14 intervention communities (with 22,070 to 90,843 Medicare fee-for-service beneficiaries per community) and 50 comparison communities from before (2006 to 2008) and during (2009 to 2010) implementation of the intervention.

The researchers found that the pre-post between-group differences showed significantly larger reductions in the intervention communities for rehospitalizations (0.56 per 1,000 per quarter; P = 0.03) and for hospitalizations (2.12 per 1,000 per quarter; P = 0.01). There was no significant difference in the mean community-wide rates of rehospitalizations as a percentage of hospital discharges before and during the intervention in the intervention communities (18.97 and 18.91 percent, respectively) or in the comparison communities (18.76 and 18.91 percent, respectively). The onset of improvement was coincident with initiating intervention, based on process control charts.

Among Medicare beneficiaries in intervention communities, compared with those in uninvolved communities, all-cause 30-day rehospitalization and all-cause hospitalization declined," the authors write. "However, there was no change in the rate of 30-day rehospitalizations as a percentage of hospital discharges."

Several authors disclosed financial ties to health care and pharmaceutical companies.
 

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 
 
Further Reading
A perioperative dose of pregabalin can reduce pain after an oculoplastic eyelid procedure, according to the results of a small study.
The cannabis-based multiple sclerosis drug Sativex has been recommended for use in Wales, making it the first in the United Kingdom to do so. The drug awaits final approval from the government.
Although, broader adoption of electronic health records has given patients access to their lab results online, a new study indicates people may not understand what they are seeing.
Eliquis is also now indicated for reducing the risk of recurrent DVT and PE following initial therapy.
Greater physical activity is associated with lower rates of incident atrial fibrillation in women, according to a study published online Aug. 20 in the Journal of the American Heart Association.
Despite the assumption that larger practices provide better healthcare, a new study found smaller practices had fewer preventable hospital admissions.
With the recent approval of new hepatitis C treatments, payers are increasingly concerned with controlling costs in this category through policies that may affect treatment decisions.
More Reading